Spotlight On Pulmonary Arterial Hypertension
Pulmonary arterial hypertension (PAH) remains a rare but serious and progressive condition that requires timely recognition, accurate diagnosis, and coordinated care across specialties. That’s why Spotlight on Pulmonary Arterial Hypertension brings together expert insights, emerging evidence, and practical clinical guidance to support clinicians involved in the care of patients with PAH.
1-15 of 16
Closing Research Gaps in Pulmonary Arterial Hypertension
Clinician's RoundtableClosing Research Gaps in Pulmonary Arterial Hypertension
John Kingrey, MD
Reducing Barriers to PAH Clinical Trial Participation
Clinician's RoundtableReducing Barriers to PAH Clinical Trial Participation
John Kingrey, MD
Gaps in Patient Representation Across PAH Clinical Trials
Clinician's RoundtableGaps in Patient Representation Across PAH Clinical Trials
John Kingrey, MD
Moving Toward Precision Medicine in PAH
Clinician's RoundtableMoving Toward Precision Medicine in PAH
Stephen Y. Chan, MD, PhD, FAHA
What’s Next for Pulmonary Arterial Hypertension Care?
Clinician's RoundtableWhat’s Next for Pulmonary Arterial Hypertension Care?
Stephen Y. Chan, MD, PhD, FAHA
Macitentan in Pediatric PAH: Results from the TOMORROW Trial
Clinician's RoundtableMacitentan in Pediatric PAH: Results from the TOMORROW Trial
- advertisement
AI in Pulmonary Hypertension Demonstrates Progress—with Caveats
Clinician's RoundtableAI in Pulmonary Hypertension Demonstrates Progress—with Caveats
Multi-Omics Brings New Clarity to the REHAB-PH Trial
Clinician's RoundtableMulti-Omics Brings New Clarity to the REHAB-PH Trial
Targeting the Hippo Pathway in Pulmonary Arterial Hypertension
AudioAbstractsTargeting the Hippo Pathway in Pulmonary Arterial Hypertension
Ryan Quigley
Leveraging Wearables for Pulmonary Arterial Hypertension Care
Clinician's RoundtableLeveraging Wearables for Pulmonary Arterial Hypertension Care
Daniel Lachant, D.O.
Bringing PAH Care Home with Wearables and Telemedicine
Clinician's RoundtableBringing PAH Care Home with Wearables and Telemedicine
Daniel Lachant, D.O.
Examining Barriers to Digital Healthcare in PAH
Clinician's RoundtableExamining Barriers to Digital Healthcare in PAH
Daniel Lachant, D.O.
- advertisement
Reframing Palliative Care in PAH: Early Integration to Improve Outcomes
Clinician's RoundtableReframing Palliative Care in PAH: Early Integration to Improve Outcomes
Targeting Macrophages in Pulmonary Arterial Hypertension
Clinician's RoundtableTargeting Macrophages in Pulmonary Arterial Hypertension
Fatty Acid Profiles May Be Linked to PAH Risk
AudioAbstractsFatty Acid Profiles May Be Linked to PAH Risk
Ryan Quigley